Switch theme
Sign up to access all valuation multiples
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.
2003
126
LTM Revenue $26.5M
LTM EBITDA -$29.8M
$169M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Avacta Group has a last 12-month revenue of $26.5M and a last 12-month EBITDA of -$29.8M.
In the most recent fiscal year, Avacta Group achieved revenue of $29.9M and an EBITDA of -$11.5M.
Avacta Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Avacta Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $29.9M | $30.2M | XXX | XXX | XXX |
| Gross Profit | $2.6M | $9.3M | XXX | XXX | XXX |
| Gross Margin | 9% | 31% | XXX | XXX | XXX |
| EBITDA | -$11.5M | -$28.7M | XXX | XXX | XXX |
| EBITDA Margin | -38% | -95% | XXX | XXX | XXX |
| Net Profit | -$33.9M | -$50.5M | XXX | XXX | XXX |
| Net Margin | -113% | -167% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Avacta Group's stock price is GBP 0 (or $0).
Avacta Group has current market cap of GBP 142M (or $183M), and EV of GBP 132M (or $169M).
See Avacta Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $169M | $183M | XXX | XXX | XXX | XXX | $-0.10 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Avacta Group has market cap of $183M and EV of $169M.
Avacta Group's trades at 6.4x LTM EV/Revenue multiple, and -5.7x LTM EBITDA.
Analysts estimate Avacta Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Avacta Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $169M | XXX | XXX | XXX |
| EV/Revenue | 5.6x | XXX | XXX | XXX |
| EV/EBITDA | -5.9x | XXX | XXX | XXX |
| P/E | -4.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -3.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAvacta Group's NTM/LTM revenue growth is -54%
Avacta Group's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Avacta Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Avacta Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Avacta Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -95% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 150% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -148% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 73% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 62% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 163% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Avacta Group acquired XXX companies to date.
Last acquisition by Avacta Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Avacta Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Avacta Group founded? | Avacta Group was founded in 2003. |
| Where is Avacta Group headquartered? | Avacta Group is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Avacta Group have? | As of today, Avacta Group has 126 employees. |
| Who is the CEO of Avacta Group? | Avacta Group's CEO is Dr. Christina Marie Coughlin. |
| Is Avacta Group publicy listed? | Yes, Avacta Group is a public company listed on LON. |
| What is the stock symbol of Avacta Group? | Avacta Group trades under AVCT ticker. |
| When did Avacta Group go public? | Avacta Group went public in 2003. |
| Who are competitors of Avacta Group? | Similar companies to Avacta Group include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Avacta Group? | Avacta Group's current market cap is $183M |
| What is the current revenue of Avacta Group? | Avacta Group's last 12-month revenue is $26.5M. |
| What is the current EBITDA of Avacta Group? | Avacta Group's last 12-month EBITDA is -$29.8M. |
| What is the current EV/Revenue multiple of Avacta Group? | Current revenue multiple of Avacta Group is 6.4x. |
| What is the current EV/EBITDA multiple of Avacta Group? | Current EBITDA multiple of Avacta Group is -5.7x. |
| What is the current revenue growth of Avacta Group? | Avacta Group revenue growth between 2023 and 2024 was 1%. |
| Is Avacta Group profitable? | Yes, Avacta Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
